Persistence of oral anticoagulant treatment for atrial fibrillation in the Netherlands: A surveillance study

Volume: 4, Issue: 1, Pages: 141 - 153
Published: Jan 1, 2020
Abstract
In contrast to vitamin K antagonists (VKA), direct oral anticoagulants (DOAC's) are not strictly monitored and dose titrated by anticoagulation clinics in the Netherlands. This may affect drug persistence of atrial fibrillation (AF) patients, whom often require lifelong treatment.To assess persistence of DOACs and of VKAs in patients with AF.Dispensing data from the Dutch Foundation of Pharmaceutical Statistics were used to monitor persistence...
Paper Details
Title
Persistence of oral anticoagulant treatment for atrial fibrillation in the Netherlands: A surveillance study
Published Date
Jan 1, 2020
Volume
4
Issue
1
Pages
141 - 153
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.